Chronic musculoskeletal pain: Review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique

Journal of Pain Research

Volumn 7, Issue , 2014, Pages 313-326

  Gerdle, Björn ^a,b   Ghafouri, Bijar ^a   Ernberg, Malin ^c   Larsson, Britt ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Clinical Immunology and Transfusion Medicine   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Algesic; Biomarker; Human; Metabolism; Nociception; Pain

Indexed keywords

ANANDAMIDE; BIOLOGICAL MARKER; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; GLUTAMIC ACID; INTERLEUKIN 6; KALLIDIN; LACTIC ACID; LEUKOTRIENE B4; PYRUVIC ACID; SEROTONIN; SUBSTANCE P;

CHRONIC MUSCULOSKELETAL PAIN; CHRONIC PAIN; FIBROMYALGIA; HUMAN; MASTICATORY MUSCLE; MICRODIALYSIS; MUSCULOSKELETAL PAIN; MYALGIA; REVIEW; SEX DIFFERENCE; TRAPEZIUS MUSCLE; WHIPLASH INJURY;

EID: 84902329538     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S59144     Document Type: Review

References (159)

1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-333.
2. Larsson B, Søgaard K, Rosendal L. Work related neck-shoulder pain: a review on magnitude, risk factors, biochemical characteristics, clinical picture and preventive interventions. Best Pract Res Clin Rheumatol. 2007;21(3):447-463.
3. Gerdle B, Björk J, Henriksson C, Bengtsson A. Prevalence of current and chronic pain and their infuences upon work and healthcare-seeking: a population study. J Rheumatol. 2004;31(7):1399-1406.
4. Côté P, van der Velde G, Cassidy JD, et al; Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. The burden and determinants of neck pain in workers: results of the Bone and Joint Decade 2 000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976). 2008;33(Suppl 4):S60-S74.
5. Croft PR, Lewis M, Papageorgiou AC, et al. Risk factors for neck pain: a longitudinal study in the general population. Pain. 2001;93(3): 317-325.
6. Hogg-Johnson S, van der Velde G, Carroll LJ, et al; Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. The burden and determinants of neck pain in the general population: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976). 2008;33(Suppl 4): S39-S51.
7. Lidgren L. Preface: neck pain and the decade of the bone and joint 2000-2010. J Manipulative Physiol Ther. 2009;32(Suppl 2):S2-S3.
8. Guez M, Hildingsson C, Nilsson M, Toolanen G, The prevalence of neck pain: a population-based study from northern Sweden. Acta Orthop Scand. 2002;73(4):455-459.
9. Gerdle B, Björk J, Cöster L, Henriksson K, Henriksson C, Bengtsson A. Prevalence of widespread pain and associations with work status: a population study. BMC Musculoskelet Disord. 2008;9:102.
10. Jesus CA, Feder D, Peres MF. The role of vitamin D in pathophysiology and treatment of fbromyalgia. Curr Pain Headache Rep. 2013;17(8):355.
11. Casarett D, Karlawish J, Sankar P, Hirschman K, Asch DA. Designing pain research from the patient's perspective: what trial end points are important to patients with chronic pain? Pain Med. 2001;2(4):309-316.
12. Robinson ME, Brown JL, George SZ, et al. Multidimensional success criteria and expectations for treatment of chronic pain: the patient perspective. Pain Med. 2005;6(5):336-345.
13. Turk DC, Dworkin RH, Revicki D, et al. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain. 2008;137(2):276-285.
14. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196.
15. Dworkin RH, Turk DC, Farrar JT, et al; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1-2):9-19.
16. World Health Organization. International Classifcation of Functioning, Disability and Health. Geneva: World Health Organization; 2001. Available from: http://www.disabilitaincifre.it/documenti/ICF_18.pdf. Accessed September 10, 2103.
17. Waddell G. 1987 Volvo award in clinical sciences. A new clinical model for the treatment of low-back pain. Spine (Phila Pa 1976). 1987;12(7): 632-644.
18. Pincus T, Kent P, Bronfort G, Loisel P, Pransky G, Hartvigsen J. Twenty-fve years with the biopsychosocial model of low back pain-is it time to celebrate? A report from the twelfth international forum for primary care research on low back pain. Spine (Phila Pa 1976). 2013;38(24):2118-2123.
19. Max MB. Towards physiologically based treatment of patients with neuropathic pain. Pain. 1990;42(2):131-137.
20. Woolf CJ, Bennett GJ, Doherty M, et al. Towards a mechanism-based classifcation of pain? Pain. 1998;77(3):227-229.
21. Ohrbach R, Gonzalez Y, List T, Michelotti A, Schiffman E. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Clinical Examination Protocol. International RDC-TMD Consortium; 2 013. Available from: http://www.rdc-tmdinternational.org/Portals/18/protocol_DC-TMD/DC-TMD%20Protocol%20-%202013_06_02.pdf. International Research Diagnostic Criteria for Temporomandibular Disorders Consortium Network; 2014. Accessed September 10, 2103.
22. Rosendal L, Larsson B, Kristiansen J, et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain. 2004;112(3):324-334.
23. Spitzer WO, Skovron ML, Salmi LR, et al. Scientifc monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefning "whiplash" and its management. Spine (Phila Pa 1 976). 1995;20(Suppl 8): 1S-73S.
24. Guzman J, Hurwitz EL, Carroll LJ, et al; Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. A new conceptual model of neck pain: linking onset, course, and care: the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976). 2008;33(Suppl 4):S14-S23.
25. Carroll LJ, Holm LW, Hogg-Johnson S, et al; Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Course and prognostic factors for neck pain in whiplash-associated disorders (WAD): results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976). 2008;33(Suppl 4):S83-S92.
26. Kamper SJ, Rebbeck TJ, Maher CG, McAuley JH, Sterling M. Course and prognostic factors of whiplash: a systematic review and meta-analysis. Pain. 2008;138(3):617-629.
27. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classifcation of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2): 160-172.
28. Kato K, Sullivan P F, Evengård B, Pedersen NL. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med. 2006;166(15):1649-1654.
29. Pace MC, Mazzariello L, Passavanti MB, Sansone P, Barbarisi M, Aurilio C. Neurobiology of pain. J Cell Physiol. 2006;209(1):8-12.
30. Mense S, Gerwin RD. Muscle pain versus skin pain. In: Mense S, Gerwin R, editors. Muscle Pain: Understanding the Mechanisms. Berlin: Springer; 2010:8-12.
31. Reichling DB, Levine JD. Critical role of nociceptor plasticity in chronic pain. Trends Neurosci. 2009;32(12):611-618.
32. Kuner R. Central mechanisms of pathological pain. Nat Med. 2010;16(11):1258-1266.
33. Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain. 2000;89(1):7-18.
34. Woolf CJ, Salter M W. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765-1769.
35. Hunt S P, Mantyh P W. Understanding the neurobiology of chronic pain: molecular and cellular biology. In: Giamberardino, MA, editor. Pain 2002 - An updated Review: Refresher Course Syllabus. Seattle: IASP Press; 2002:237-247.
36. Petersen-Felix S, Curatolo M. Neuroplasticity - an important factor in acute and chronic pain. Swiss Med Wkly. 2002;132(21/22):273-278.
37. Wilder-Smith OH, Tassonyi E, Arendt-Nielsen L. Preoperative back pain is associated with diverse manifestations of central neuroplasticity. Pain. 2002;97(3):189-194.
38. Schmidt-Wilcke T. Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep. 2008;10(6): 467-474.
39. International Association for the Study of Pain [homepage on the Internet]. IASP Taxonomy; 1994 [updated May 22, 2012]. Available from: https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698. Accessed September 10, 2103.
40. Mense S. The pathogenesis of muscle pain. Curr Pain Headache Rep. 2003;7(6):419-425.
41. Woolf CJ, Ma Q. Nociceptors - noxious stimulus detectors. Neuron. 2007;55(3):353-364.
42. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain. 1993;54(3):241-289.
43. Coutaux A, Adam F, Willer JC, Le Bars D. Hyperalgesia and allodynia: peripheral mechanisms. Joint Bone Spine. 2005;72(5):359-371.
44. Mense S. Algesic agents exciting muscle nociceptors. Exp Brain Res. 2009;196(1):89-100.
45. Momin A, McNaughton PA. Regulation of firing frequency in nociceptive neurons by pro-infammatory mediators. Exp Brain Res. 2009;196(1):45-52.
46. Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated infammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol. 2000;130(6):1418-1424.
47. Poole S, Cunha FQ, Selkirk S, Lorenzetti BB, Ferreira SH. Cytokine-mediated infammatory hyperalgesia limited by interleukin-10. Br J Pharmacol. 1995;115(4):684-688.
48. Verri WA Jr, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther. 2006;112(1):116-138.
49. Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3): 389-462.
50. Piomelli D, Sasso O. Peripheral gating of pain signals by endogenous lipid mediators. Nat Neurosci. 2014;17(2):164-174.
51. Serhan CN, Petasis NA. Resolvins and protectins in infammation resolution. Chem Rev. 2011;111(10):5922-5943.
52. Linley JE, Rose K, Ooi L, Gamper N. Understanding infammatory pain: ion channels contributing to acute and chronic nociception. Pfugers Arch. 2010;459(5):657-669.
53. Schaible HG, Richter F, Ebersberger A, et al. Joint pain. Exp Brain Res. 2009;196(1):153-162.
54. Almeida TF, Roizenblatt S, Tufk S. Afferent pain pathways: a neuro-anatomical review. Brain Res. 2004;1000(1-2):40-56.
55. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26(12):696-705.
56. Gangadharan V, Kuner R. Pain hypersensitivity mechanisms at a glance. Dis Model Mech. 2013;6(4):889-895.
57. Lee MC, Tracey I. Unravelling the mystery of pain, suffering, and relief with brain imaging. Curr Pain Headache Rep. 2010;14(2): 124-131.
58. Legrain V, Iannetti GD, Plaghki L, Mouraux A. The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol. 2011;93(1):111-124.
59. Iannetti GD, Mouraux A. From the neuromatrix to the pain matrix (and back). Exp Brain Res. 2010;205(1):1-12.
60. Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Invest. 2010;120(11):3779-3787.
61. Schweinhardt P, Bushnell MC. Pain imaging in health and disease - how far have we come? J Clin Invest. 2010;120(11):3788-3797.
62. Apkarian AV. Pain perception in relation to emotional learning. Curr Opin Neurobiol. 2008;18(4):464-468.
63. Baliki MN, Schnitzer TJ, Bauer WR, Apkarian AV. Brain morphological signatures for chronic Pain. PLoS One. 2011;6(10):e26010.
64. Napadow V, Kim J, Clauw DJ, Harris RE. Decreased intrinsic brain connectivity is associated with reduced clinical pain in fbromyalgia. Arthritis Rheum. 2012;64(7):2398-2403.
65. Ji RR, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain. 2013;154 (Suppl 1):S10-S28.
66. Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: Specifcity, recruitment and plasticity. Brain Res Rev. 2009;60(1):214-225.
67. Porreca F, Ossipov MH, Gebhart G F. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002;25(6):319-325.
68. Ren K, Dubner R. Descending modulation in persistent pain: an update. Pain. 2002;100(1-2):1-6.
69. Robinson DA, Zhuo M. Genetic analysis of pain mechanisms. Crit Rev Eukaryot Gene Expr. 2002;12(4):275-295.
70. Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fbromyalgia is related to a defcit of endogenous pain inhibition. Pain. 2005;114(1/2):295-302.
71. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(Suppl 3):S2-S15.
72. Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009; 122(Suppl 12):S22-S30.
73. Petersel DL, Dror V, Cheung R. Central amplifcation and fbromyalgia: disorder of pain processing. J Neurosci Res. 2011;89(1):29-34.
74. Smith HS, Harris R, Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011;14(2):E217-E245.
75. Schneider GM, Smith AD, Hooper A, et al. Minimizing the source of nociception and its concurrent effect on sensory hypersensitivity: an exploratory study in chronic whiplash patients. BMC Musculoskelet Disord. 2010;11:29.
76. Staud R, Nagel S, Robinson ME, Price DD. Enhanced central pain processing of fbromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain. 2009;145(1-2):96-104.
77. Staud R. Is it all central sensitization? Role of peripheral tissue nocicep-tion in chronic musculoskeletal pain. Curr Rheumatol Rep. 2010;12(6): 448-454.
78. Wallin M, Liedberg G, Börsbo B, Gerdle B. Thermal detection and pain thresholds but not pressure pain thresholds are correlated with psychological factors in women with chronic whiplash-associated pain. Clin J Pain. 2012;28(3):211-221.
79. Reichling DB, Green PG, Levine JD. The fundamental unit of pain is the cell. Pain. 2013;154 Suppl 1.
80. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med. 1991;230(4):365-373.
81. Gerdle B, Larsson B. Potential muscle biomarkers of chronic myalgia in humans - a systematic review of microdialysis studies. In: Khan TK, editor. Biomarker. Open access: InTech; 2012:103-132.
82. Ernberg M, Gerdle B. Peripheral Algesic Substances in Musculoskeletal Pain Assessed by Microdialysis. In: Graven-Nielsen T, Arendt-Nielsen L, editors. Musculoskeletal Pain - Basic Mechanisms and Implications. IASP Press; 2014. In press.
83. Waelgaard L, Pharo A, Tønnessen TI, Mollnes TE. Microdialysis for monitoring infammation: effcient recovery of cytokines and anaphylotoxins provided optimal catheter pore size and fuid velocity conditions. Scand J Immunol. 2006;64(3):345-352.
84. Olausson P, Gerdle B, Ghafouri N, Karlsson L, Larsson B, Ghafouri B. Relative recovery over time - an in vivo microdialysis study of human skeletal muscle. Scand J Clin Lab Invest. 2013;73(1):10-16.
85. Hickner RC, Bone D, Ungerstedt U, Jorfeldt L, Henriksson J. Muscle blood fow during intermittent exercise: comparison of the microdi-alysis ethanol technique and 133Xe clearance. Clin Sci (Lond). 1994;86(1):15-25.
86. Stallknecht B, Donsmark M, Enevoldsen LH, Fluckey JD, Galbo H. Estimation of rat muscle blood flow by microdialysis probes perfused with ethanol, [14C]ethanol, and 3H2O. J Appl Physiol. 1999;86(3):1054-1061.
87. Castrillon EE, Ernberg M, Cairns BE, et al. Interstitial glutamate concentration is elevated in the masseter muscle of myofascial temporo-mandibular disorder patients. J Orofac Pain. 2010;24(4):350-360.
88. Flodgren GM, Crenshaw AG, Alfredson H, et al. Glutamate and prostaglandin E2 in the trapezius muscle of female subjects with chronic muscle pain and controls determined by microdialysis. Eur J Pain. 2005;9(5):511-515.
89. Larsson B, Rosendal L, Kristiansen J, et al. Responses of algesic and metabolic substances to 8 h of repetitive manual work in myalgic human trapezius muscle. Pain. 2008;140(3):479-490.
90. Shah J P, Danoff J V, Desai MJ, et al. Biochemicals associated with pain and infammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89(1): 16-23.
91. Shah J P, Phillips TM, Danoff J V, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol (1985). 2005;99(5):1977-1984.
92. Ghafouri B, Larsson BK, Sjörs A, Leandersson P, Gerdle BU. Interstitial concentration of serotonin is increased in myalgic human trapezius muscle during rest, repetitive work and mental stress - an in vivo microdialysis study. Scand J Clin Lab Invest. 2010;70(7):478-486.
93. Gerdle B, Hilgenfeldt U, Larsson B, Kristiansen J, Søgaard K, Rosendal L. Bradykinin and kallidin levels in the trapezius muscle in patients with work-related trapezius myalgia, in patients with whiplash associated pain, and in healthy controls - A microdialysis study of women. Pain. 2008;139(3):578-587.
94. Sjøgaard G, Rosendal L, Kristiansen J, et al. Muscle oxygenation and glycolysis in females with trapezius myalgia during stress and repetitive work using microdialysis and NIRS. Eur J Appl Physiol. 2010;108(4):657-669.
95. Rosendal L, Kristiansen J, Gerdle B, et al. Increased levels of interstitial potassium but normal levels of muscle IL-6 and LDH in patients with trapezius myalgia. Pain. 2005;119(1-3):201-209.
96. Flodgren GM, Crenshaw AG, Hellström F, Fahlström M. Combining microdialysis and near-infrared spectroscopy for studying effects of low-load repetitive work on the intramuscular chemistry in trapezius myalgia. J Biomed Biotechnol. 2010;2010:513803.
97. Flodgren GM, Hellström FB, Fahlström M, Crenshaw AG. Effects of 30 versus 6 0 min of low-load work on intramuscular lactate, pyruvate, glutamate, prostaglandin E(2) and oxygenation in the trapezius muscle of healthy females. Eur J Appl Physiol. 2006;97(5):557-565.
98. Gerdle B, Lemming D, Kristiansen J, Larsson B, Peolsson M, Rosendal L. Biochemical alterations in the trapezius muscle of patients with chronic whiplash associated disorders (WAD) - a microdialysis study. Eur J Pain. 2008;12(1):82-93.
99. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. The level of serotonin in the superfcial masseter muscle in relation to local pain and allodynia. Life Sci. 1999;65(3):313-325.
100. Hedenberg-Magnusson B, Ernberg M, Alstergren P, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand. 2001;59(6):348-355.
101. McIver KL, Evans C, Kraus RM, Ispas L, Sciotti VM, Hickner RC. NO-mediated alterations in skeletal muscle nutritive blood fow and lactate metabolism in fbromyalgia. Pain. 2006;120(1/2):161-169.
102. Gerdle B, Soderberg K, Salvador Puigvert L, Rosendal L, Larsson B. Increased interstitial concentrations of pyruvate and lactate in the trapezius muscle of patients with fbromyalgia: a microdialysis study. J Rehabil Med. 2010;42(7):679-687.
103. Gerdle B, Larsson B, Forsberg F, et al. Chronic widespread pain: increased glutamate and lactate concentrations in the trapezius muscle and plasma. Clin J Pain. 2014;30(5):409-420.
104. Ghafouri N, Ghafouri B, Larsson B, et al. High levels of N- palmitoylethanolamide and N-stearoylethanolamide in microdi-alysate samples from myalgic trapezius muscle in women. PLOS One. 2011;6(11):e27257.
105. Ghafouri N, Ghafouri B, Larsson B, Stensson N, Fowler CJ, Gerdle B. Palmitoylethanolamide and stearoylethanolamide levels in the inter-stitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity. Pain. 2013;154(9):1649-1658.
106. Olausson P, Gerdle B, Ghafouri N, Larsson B, Ghafouri B. Identifcation of proteins from interstitium of trapezius muscle in women with chronic myalgia using microdialysis in combination with proteomics. PLoS One. 2012;7(12):e52560.
107. Hadrévi J, Ghafouri B, Sjörs A, et al. Comparative metabolomics of muscle interstitium fuid in human trapezius myalgia: an in vivo microdialysis study. Eur J Appl Physiol. 2013;113(12):2977-2989.
108. Sommer C. Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol. 2004;30(2):117-125.
109. Ernberg M. Serotonergic Receptor involvement in Muscle Pain and Hyperalgesia. In: Graven-Nielsen T, Arendt-Nielsen L, Mense S, editors. Fundamentals of Musculoskeltal Pain. 1st ed. Seattle: IASP Press; 2008:139-153.
110. Giordano J, Rogers LV. Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol. 1989;170(1/2):83-86.
111. Taiwo YO, Levine JD. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience. 1992;48(2):485-490.
112. Ernberg M, Hedenberg-Magnusson B, Kurita H, Kopp S. Effects of local serotonin administration on pain and microcirculation in the human masseter muscle. J Orofac Pain. 2006;20(3):241-248.
113. Coggeshall RE, Carlton SM. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res Brain Res Rev. 1997;24(1):28-66.
114. Hudspith MJ. Glutamate: a role in normal brain function, anaesthesia, analgesia and CNS injury. Br J Anaesth. 1997;78(6):731-747.
115. Quintero GC. Advances in cortical modulation of pain. J Pain Res. 2013;6:713-725.
116. Carlton SM. Peripheral excitatory amino acids. Curr Opin Pharmacol. 2001;1(1):52-56.
117. Varney MA, Gereau RW. Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics. Curr Drug Targets CNS Neurol Disord. 2002;1(3):283-296.
118. Cairns BE, Sessle BJ, Hu JW. Characteristics of glutamate-evoked temporomandibular joint afferent activity in the rat. J Neurophysiol. 2001;85(6):2446-2454.
119. Cairns BE, Hu J W, Arendt-Nielsen L, Sessle BJ, Svensson P. Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 2001;86(2):782-789.
120. Cairns BE, Wang K, Hu J W, Sessle BJ, Arendt-Nielsen L, Svensson P. The effect of glutamate-evoked masseter muscle pain on the human jaw-stretch refex differs in men and women. J Orofac Pain. 2003;17(4):317-325.
121. Svensson P, Cairns BE, Wang K, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain. 2003;101(3):221-227.
122. Svensson P, Wang K, Arendt-Nielsen L, Cairns BE, Sessle BJ. Pain effects of glutamate injections into human jaw or neck muscles. J Orofac Pain. 2005;19(2):109-118.
123. Tegeder L, Zimmermann J, Meller S, Geisslinger G. Release of algesic substances in human experimental muscle pain. Infamm Res. 2002;51(8):393-402.
124. Miller KE, Hoffman EM, Sutharshan M, Schechter R. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther. 2011;130(3):283-309.
125. Gazerani P, Wang K, Cairns BE, Svensson P, Arendt-Nielsen L. Effects of subcutaneous administration of glutamate on pain, sensi-tization and vasomotor responses in healthy men and women. Pain. 2006;124(3):338-348.
126. Cairns BE, Dong X. The role of peripheral glutamate and glutamate receptors in muscle pain. J Musculoskelet Pain. 2008;16(1/2): 85-91.
127. Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fbromy-algia and other musculoskeletal disorders. Curr Pain Headache Rep. 2003;7(5):355-361.
128. Elvin A, Siösteen AK, Nilsson A, Kosek E. Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: a contrast media enhanced colour Doppler study. Eur J Pain. 2006;10(2):137-144.
129. Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fbromyalgia. Scand J Rheumatol. 1986;15(2):165-173.
130. Sandberg M, Lindberg LG, Gerdle B. Peripheral effects of needle stimulation (acupuncture) on skin and muscle blood flow in fbromyalgia. Eur J Pain. 2004;8(2):163-171.
131. Bengtsson A. The muscle in fbromyalgia. Rheumatology (Oxford). 2002;41(7):721-724.
132. Larsson B, Björk J, Kadi F, Lindman R, Gerdle B. Blood supply and oxidative metabolism in muscle biopsies of female cleaners with and without myalgia. Clin J Pain. 2004;20(6):440-446.
133. Philip A, Macdonald AL, Watt P W. Lactate - a signal coordinating cell and systemic function. J Exp Biol. 2005;208(Pt 24):4561-4575.
134. Weibel ER, Hoppeler H. Exercise-induced maximal metabolic rate scales with muscle aerobic capacity. J Exp Biol. 2005;208(Pt 9): 1635-1644.
135. Norrbom J. Exercise and Regulation of Mithochondrial Biogenesis Factors in Human Skeletal Muscle [doctoral thesis]. Stockholm, Karolinska Institute; 2008.
136. Bengtsson A, Henriksson KG, Larsson J. Muscle biopsy in primary fbromyalgia. Light-microscopical and histochemical fndings. Scand J Rheumatol. 1986;15(1):1-6.
137. Larsson B, Björk J, Henriksson KG, Gerdle B, Lindman R. The prevalences of cytochrome c oxidase negative and superpositive fbres and ragged-red fbres in the trapezius muscle of female cleaners with and without myalgia and of female healthy controls. Pain. 2000;84(2/3):379-387.
138. Kim TJ, Freml L, Park SS, Brennan TJ. Lactate concentrations in incisions indicate ischemic-like conditions may contribute to postoperative pain. J Pain. 2007;8(1):59-66.
139. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol. 2004;558(Pt 1):5-30.
140. Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol. 2004;287(3):R502-R516.
141. Cairns S P. Lactic acid and exercise performance: culprit or friend? Sports Med. 2006;36(4):279-291.
142. Eisenhut M, Wallace H. Ion channels in infammation. Pfugers Arch. 2011;461(4):401-421.
143. Lee Y, Lee CH, Oh U. Painful channels in sensory neurons. Mol Cells. 2005;20(3):315-324.
144. Barbieri E, Sestili P. Reactive oxygen species in skeletal muscle signaling. J Signal Transduct. 2012;2012:982794.
145. Cruz RS, de Aguiar RA, Turnes T, Penteado Dos Santos R, de Oliveira MF, Caputo F. Intracellular shuttle: the lactate aerobic metabolism. ScientifcWorldJournal. 2012;2012:420984.
146. Lanza IR, Nair KS. Mitochondrial function as a determinant of life span. Pfugers Arch. 2010;459(2):277-289.
147. Kallenborn-Gerhardt W, Schröder K, Geisslinger G, Schmidtko A. NOXious signaling in pain processing. Pharmacol Ther. 2013;137(3): 309-317.
148. Schaible HG, Ebersberger A, Natura G. Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines. Arthritis Res Ther. 2011;13(2):210.
149. Sacerdote P, Levrini L. Peripheral mechanisms of dental pain: the role of substance P. Mediators Infamm. 2012;2012:951920.
150. Harrison S, Geppetti P. Substance p. Int J Biochem Cell Biol. 2001; 33(6):555-576.
151. Iannone F, Lapadula G. Obesity and infammation - targets for OA therapy. Curr Drug Targets. 2010;11(5):586-598.
152. Graven-Nielsen T, McArdle A, Phoenix J, et al. In vivo model of muscle pain: quantifcation of intramuscular chemical, electrical, and pressure changes associated with saline-induced muscle pain in humans. Pain. 1997;69(1/2):137-143.
153. Marchand S. The Phenomenon of Pain. 1st edition. Seattle: IASP Press; 2012.
154. Wang H, Ehnert C, Brenner GJ, Woolf CJ. Bradykinin and peripheral sensitization. Biol Chem. 2006;387(1):11-14.
155. Riedel W, Neeck G. Nociception, pain, and antinociception: current concepts. Z Rheumatol. 2001;60(6):404-415.
156. Levine JD, Reichling DB. Peripheral mechanisms of infammatory pain. In: Wall PD, Melzack R, editors. Textbook of Pain. 4th ed. Edinburgh: Churchill Livingstone; 1999:59-84.
157. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in infammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361(1/3):184-187.
158. Uçeyler N, Schäfers M, Sommer C. Mode of action of cytokines on nociceptive neurons. Exp Brain Res. 2009;196(1):67-78.
159. Helmy A, Carpenter KL, Skepper JN, Kirkpatrick PJ, Pickard JD, Hutchinson PJ. Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery. J Neurotrauma. 2009;26(4):549-561.